Alterity Therapeutics Limited (ATHE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 3.83M | 1.61M | 2.12M | 1.9M | 1.53M | 2.39M | 2.76M | 2.36M | 2.46M | 1.88M | -1.86M |
| Revenue Growth % | -100% | 80.92% | -15.51% | 38.42% | -20.33% | -44.63% | 1.13% | 12.54% | 25.27% | 232.4% | 1.52% | -173.48% |
| Cost of Goods Sold | 56.83K | 63.92K | 63.6K | 73.61K | 73.92K | 52.27K | 50K | 22.68K | 31.54K | 39.74K | 35.63K | 250.69K |
| COGS % of Revenue | - | 1.67% | 3.96% | 3.47% | 3.89% | 3.42% | 2.1% | 0.82% | 1.34% | 1.62% | 1.89% | -13.51% |
| Gross Profit | -56.83K | 3.77M | 1.54M | 2.04M | 1.83M | 1.48M | 2.34M | 2.74M | 2.33M | 2.42M | 1.85M | -2.11M |
| Gross Margin % | - | 98.33% | 96.04% | 96.53% | 96.11% | 96.58% | 97.9% | 99.18% | 98.66% | 98.38% | 98.11% | 113.51% |
| Gross Profit Growth % | -103.68% | 84.31% | -15.57% | 38.34% | -21.79% | -46.08% | 0.35% | 13.45% | 25.98% | 214.75% | 5.41% | -192.15% |
| Operating Expenses | 12.76M | 10.86M | 9.03M | 14.98M | 8.45M | 7.72M | 10.7M | 10.44M | 10.13M | 9.84M | 9.6M | 6.04M |
| OpEx % of Revenue | - | 283.26% | 562.2% | 707.29% | 444.32% | 504.48% | 448.47% | 377.65% | 429.41% | 400.43% | 510% | -325.44% |
| Selling, General & Admin | 5.06M | 2.17M | 3.31M | 2.68M | 2.08M | 2.29M | 2.94M | 2.46M | 3.37M | 3.36M | 3.8M | 1.69M |
| SG&A % of Revenue | - | 56.64% | 206.15% | 126.42% | 109.66% | 149.4% | 123.05% | 88.82% | 142.81% | 136.74% | 201.67% | -90.89% |
| Research & Development | 7.7M | 8.69M | 5.72M | 12.28M | 6.36M | 5.43M | 7.76M | 7.98M | 6.76M | 6.48M | 5.81M | 4.35M |
| R&D % of Revenue | - | 226.62% | 356.05% | 579.78% | 334.66% | 355.08% | 325.43% | 288.83% | 286.6% | 263.69% | 308.33% | -234.56% |
| Other Operating Expenses | 0 | 0 | 0 | 23.05K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.82M | -7.09M | -7.49M | -12.98M | -4.5M | -7.77M | -10.75M | -10.46M | -10.16M | -9.88M | -9.64M | -8.14M |
| Operating Margin % | - | -184.92% | -466.16% | -612.83% | -236.75% | -507.89% | -450.57% | -378.47% | -430.75% | -402.05% | -511.89% | 438.96% |
| Operating Income Growth % | -71.22% | 45.41% | -66.36% | -67.02% | 58.14% | 25.7% | -5.78% | -5.94% | -5.41% | -21.27% | -67.89% | -14.94% |
| EBITDA | -12.76M | -7.08M | -7.47M | -12.91M | -4.43M | -7.72M | -10.7M | -10.44M | -10.13M | -9.84M | -9.6M | -8.13M |
| EBITDA Margin % | - | -184.63% | -465.11% | -609.36% | -232.86% | -504.48% | -448.47% | -377.65% | -429.41% | -400.43% | -510% | 438.33% |
| EBITDA Growth % | -70.85% | 45.18% | -68.76% | -67.2% | 58.63% | 26.04% | -5.62% | -6.14% | -5.47% | -20.95% | -68.96% | -15.02% |
| D&A (Non-Cash Add-back) | 56.83K | 11.45K | 16.86K | 73.61K | 73.92K | 52.27K | 50K | 22.68K | 31.54K | 39.74K | 35.63K | 11.6K |
| EBIT | -12.82M | -7.12M | -7.54M | -14.69M | -8.41M | -7.3M | -10.31M | -8.73M | -8.72M | -8.99M | -10.45M | -8.15M |
| Net Interest Income | 893.06K | 334.99K | 111.3K | 150.02K | 118.4K | 5.06K | 11.38K | 1.15K | 1.35K | 14.12K | 6.55K | 2.98K |
| Interest Income | 893.06K | 334.99K | 111.3K | 150.02K | 118.4K | 5.06K | 11.38K | 1.15K | 1.35K | 14.12K | 6.55K | 2.98K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 686.86K | 2.18M | -1.29M | -1.71M | 111.34K | 470.83K | 435.95K | 1.73M | 1.45M | 884.83K | -804.63K | 326.86K |
| Pretax Income | -12.13M | -4.91M | -8.78M | -14.69M | -4.39M | -7.3M | -10.31M | -8.73M | -8.72M | -8.99M | -10.45M | -7.82M |
| Pretax Margin % | - | -128.01% | -546.68% | -693.34% | -230.89% | -477.13% | -432.3% | -315.79% | -369.49% | -366.02% | -554.61% | 421.34% |
| Income Tax | -2.69M | 68.06K | -1.61M | -2.07M | -1.9M | -1.53M | -2.28M | -2.47M | -2.13M | -2.24M | -1.88M | 0 |
| Effective Tax Rate % | 22.19% | -1.39% | 18.29% | 14.11% | 43.31% | 20.92% | 22.12% | 28.25% | 24.47% | 24.95% | 18.03% | 0% |
| Net Income | -9.44M | -4.97M | -7.17M | -12.62M | -6.51M | -5.77M | -8.03M | -6.26M | -6.58M | -6.75M | -8.56M | -7.82M |
| Net Margin % | - | -129.78% | -446.68% | -595.51% | -342.35% | -377.3% | -336.65% | -226.58% | -279.06% | -274.7% | -454.61% | 421.34% |
| Net Income Growth % | -31.59% | 60.57% | -10.24% | -118.48% | 18.98% | 7.81% | -22% | 7.17% | 23.11% | 13.68% | -51.8% | -11.7% |
| Net Income (Continuing) | -9.44M | -4.97M | -7.17M | -12.62M | -6.51M | -5.77M | -8.03M | -6.26M | -6.58M | -6.75M | -8.56M | -7.82M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.54 | -0.42 | -0.84 | -1.20 | -1.56 | -1.44 | -1.98 | -1.56 | -1.62 | -1.92 | -3.90 | -5.10 |
| EPS Growth % | 35.71% | 65% | 46.15% | 16.67% | 21.21% | 7.69% | -22.22% | 18.75% | 58.46% | 62.35% | 0% | 15.84% |
| EPS (Basic) | -0.54 | -0.42 | -0.84 | -1.20 | -1.56 | -1.44 | -1.98 | -1.56 | -1.62 | -1.92 | -3.90 | -5.10 |
| Diluted Shares Outstanding | 16.97M | 12.47M | 8.86M | 10.51M | 4.17M | 4.07M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M | 1.54M |
| Basic Shares Outstanding | 16.97M | 12.47M | 8.54M | 10.51M | 4.17M | 4.07M | 4.02M | 4.01M | 4.01M | 3.47M | 2.21M | 1.54M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |